Targeting RNA with small molecules is an emerging field.
While
several ligands for different RNA targets are reported, structure-based
virtual screenings (VSs) against RNAs are still rare. Here, we elucidated
the general capabilities of protein-based docking programs to reproduce
native binding modes of small-molecule RNA ligands and to discriminate
known binders from decoys by the scoring function. The programs were
found to perform similar compared to the RNA-based docking tool rDOCK,
and the challenges faced during docking, namely, protomer and tautomer
selection, target dynamics, and explicit solvent, do not largely differ
from challenges in conventional protein-ligand docking. A prospective
VS with the Bacillus subtilis preQ1-riboswitch aptamer domain performed with FRED, HYBRID, and
FlexX followed by microscale thermophoresis assays identified six
active compounds out of 23 tested VS hits with potencies between 29.5
nM and 11.0 μM. The hits were selected not solely based on their
docking score but for resembling key interactions of the native ligand.
Therefore, this study demonstrates the general feasibility to perform
structure-based VSs against RNA targets, while at the same time it
highlights pitfalls and their potential solutions when executing RNA–ligand
docking.